NVS Competitors & Alternatives
Compare Novartis AG with similar stocks in the same industry
Pharmaceutical Preparations
NVS
Main Stock$149.72
Tradestie Score
52
Market Cap
$254.99B
P/E Ratio
20.9
Revenue Growth
0.0%
Analyst Upside
+0.4%
Top Competitors
553 stocks in Pharmaceutical Preparations| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$892.20
|
$739.95B | 39.1 | 51 | Compare |
|
JNJ
Johnson & Johnson
|
$241.23
|
$448.07B | 21.7 | 61 | Compare |
|
ABBV
ABBVIE INC.
|
$212.27
|
$431.71B | 89.5 | 55 | Compare |
|
NVO
Novo-Nordisk A/S
|
$35.36
|
$262.92B | 10.2 | 57 | Compare |
|
AZN
AstraZeneca PLC
|
$193.07
|
$261.56B | 28.0 | 61 | Compare |
|
ABT
Abbott Laboratories
|
$103.35
|
$232.30B | 28.1 | 56 | Compare |
|
MRK
Merck & Co., Inc.
|
$119.52
|
$225.13B | 16.3 | 68 | Compare |
|
PFE
Pfizer Inc.
|
$27.30
|
$154.70B | 20.3 | 65 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$46.56
|
$121.27B | 19.9 | 62 | Compare |
|
VRTX
Vertex Pharmaceuticals Inc
|
$441.20
|
$103.64B | 29.6 | 42 | Compare |
More NVS Analysis
Data updated: Mar 30, 2026 | Industry: Pharmaceutical Preparations (SIC 2834)
553 stocks in this industry